McKesson Corporation – Consensus Indicates Potential -2.1% Downside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

McKesson Corporation with ticker code (MCK) have now 13 analysts in total covering the stock. The consensus rating is ‘Buy’. The range between the high target price and low target price is between 300 and 230 calculating the mean target price we have 268.08. Now with the previous closing price of 273.9 this indicates there is a potential downside of -2.1%. The day 50 moving average is 249.38 and the 200 moving average now moves to 213.88. The market capitalisation for the company is $42,113m. Visit the company website at: https://www.mckesson.com

The potential market cap would be $41,218m based on the market concensus.

McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search